文献速递肝病

特定肠道与唾液微生物群模式与轻微肝性脑病不同认知测试策略相关

Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

研究纳入247例肝硬化门诊患者,采用PHES、抑制控制测试和EncephalApp Stroop评估轻微肝性脑病(MHE),并行粪便及部分唾液16srRNA测序。不同测试间MHE患病率为59%-82%,测试间Kappa仅0.15-0.35;粪便和唾液乳杆菌科在MHE患者中相对丰度较高,而自身劳特罗普菌科在无MHE者中较高。

要点

  • 不同认知测试诊断MHE的一致性差,测试间Kappa为0.15-0.35。
  • 粪便和唾液乳杆菌科相对丰度在MHE患者中较高,与所用测试无关。
  • 粪便和唾液劳特罗普菌科与良好认知相关,独立于临床变量。

核心结论

  • MHE存在针对各认知测试策略的特定粪便和唾液微生物特征。
  • 与良好认知功能相关的特定菌群与测试方式无关,可能用于规避MHE测试。

研究设计与样本

  • 肝硬化门诊患者行粪便采集及MHE测试(PHES、抑制控制测试、EncephalApp Stroop),部分患者提供唾液样本,行16srRNA测序分析粪便和唾液微生物群。

主要发现

  • 247例肝硬化患者(123例既往显性HE,MELD 13)接受粪便采集和PHES测试,175例接受抑制控制测试,125例接受Stroop测试,112例同时提供唾液样本。
  • 根据测试方式不同,59%-82%的患者存在MHE,测试间Kappa为0.15-0.35。
  • 粪便和唾液乳杆菌科相对丰度在MHE患者中较高,与所用测试方式无关;自身劳特罗普菌科在无MHE者中较高,尤其在PHES测试中。
  • 逻辑回归显示,粪便和唾液劳特罗普菌科菌属(瘤胃球菌属和梭菌XIVb)与良好认知相关,独立于临床变量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minimal hepatic encephalopathy (MHE) is epidemic in cirrhosis, but testing strategies often have poor concordance. Altered gut/salivary microbiota occur in cirrhosis and could be related to MHE. Our aim was to determine microbial signatures of individual cognitive tests and define the role of microbiota in the diagnosis of MHE. METHODS: Outpatients with cirrhosis underwent stool collection and MHE testing with psychometric hepatic encephalopathy score (PHES), inhibitory control test, and EncephalApp Stroop. A subset provided saliva samples. Minimal hepatic encephalopathy diagnosis/concordance between tests was compared. Stool/salivary microbiota were analyzed using 16srRNA sequencing. Microbial profiles were compared between patients with/without MHE on individual tests. Logistic regression was used to evaluate clinical and microbial predictors of MHE diagnosis. RESULTS: Two hundred forty-seven patients with cirrhosis (123 prior overt HE, MELD 13) underwent stool collection and PHES testing; 175 underwent inhibitory control test and 125 underwent Stroop testing. One hundred twelve patients also provided saliva samples. Depending on the modality, 59%-82% of patients had MHE. Intertest Kappa for MHE was 0.15-0.35. Stool and salivary microbiota profiles with MHE were different from those without MHE. Individual microbiota signatures were associated with MHE in specific modalities. However, the relative abundance of Lactobacillaceae in the stool and saliva samples was higher in MHE, regardless of the modality used, whereas autochthonous Lachnospiraceae were higher in those without MHE, especially on PHES. On logistic regression, stool and salivary Lachnospiraceae genera (Ruminococcus and Clostridium XIVb) were associated with good cognition independent of clinical variables. DISCUSSION: Specific stool and salivary microbial signatures exist for individual cognitive testing strategies in MHE. The presence of specific taxa associated with good cognitive function regardless of modality could potentially be used to circumvent MHE testing.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Fagan A, White MB, et al. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. Am J Gastroenterol. 2019. PMID: 30816877. doi:10.14309/ajg.0000000000000102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。